Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Neuroprotection in Elderly Cardiac Surgery
NCT01561378Phase 2Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Aug 2012
- Primary completion
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of insulin aspart in post-operative cognitive decline (POCD) and postoperative delirium (POD) (2 arms), sponsored by Albert Einstein College of Medicine. Primary endpoint: Change From Baseline Cognitive Function at 6 weeks. Started Aug 2012; status: completed.
02
Drugs
insulin aspart
03
Conditions
post-operative cognitive decline (POCD)postoperative delirium (POD)
Beyond the preview
Go deeper on NCT01561378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01561378.